GlassScriptPhysician profile
Amira An Hall
NPI 1679032635
$2,389.00
in general payments reported to CMS, 2019-2025
34 companies · $744 in 2025
The $744 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $252 · 2023: $628 · 2024: $765 · 2025: $744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,136.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $429.99 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $244.32 | 2023-2025 | |
| Exact Sciences Corporation | $229.82 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $217.70 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $144.13 | 2024-2025 | |
| Lilly USA, LLC | $137.63 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Astellas Pharma US INC | $80.31 | 2024-2025 | Veozah |
| Merck Sharp & Dohme LLC | $71.72 | 2022-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Gilead Sciences, INC. | $67.64 | 2025 | |
| Amgen INC. | $62.14 | 2023-2024 | Evenity, Prolia |
| Janssen Pharmaceuticals, INC | $55.64 | 2023-2024 | Xarelto, Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.20 | 2022-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $47.55 | 2022-2023 | |
| Glaxosmithkline, LLC. | $42.34 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Xeris Pharmaceuticals, INC. | $42.05 | 2024-2025 | Gvoke Hypopen |
Show all 34 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amira Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.